Mark B. Abelson
23Patents
5h-index
16Co-inventors
66Inventor score
Filing activity: Aug 8, 1980 → May 27, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4981871A | Treatment of ocular hypertension with class I calcium channel blocking agents | Human Necessities | 74 | Expired |
| US5431907A | Treatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agents | Human Necessities | 23 | Expired |
| US5435998A | Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents | Human Necessities | 22 | Expired |
| US8685439B2 | Method for the treatment and prevention of eyelid swelling | Human Necessities | 16 | Active |
| US4315024A | Compositions and method for treating red eye | Human Necessities | 8 | Expired |
| USD875946S1 | Apparatus for capturing an image of the eye | General | 4 | Active |
| US8664215B2 | Ocular allergy treatments with alcaftadine | Human Necessities | 3 | Active |
| US9993471B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 2 | Active |
| US8372814B2 | Ophthalmic formulations and uses thereof | Human Necessities | 2 | Active |
| US9254286B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 2 | Active |
| US8569273B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 2 | Active |
| US10675279B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 2 | Active |
| US6465506B2 | Instillation techniques for ophthalmic agents to enhance treatment effect | Human Necessities | 2 | Expired |
| US9750684B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 2 | Active |
| US10603303B2 | Transient receptor potential cation channel subfamily M member 8 (TRPM8) antagonists and methods of use | Human Necessities | 1 | Active |
| US8748402B2 | Ophthalmic formulations and uses thereof | Human Necessities | 1 | Active |
| US12048685B2 | Transient receptor potential cation channel subfamily m member 8 (TRPM8) antagonists and methods of use | Human Necessities | 0 | Active |
| US10617695B2 | Ophthalmic compositions containing alcaftadine | Human Necessities | 0 | Active |
| US11617749B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 0 | Active |
| US10987352B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 0 | Active |
| US11246483B2 | Apparatus for capturing an image of the eye | Physics | 0 | Active |
| US8829005B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 0 | Active |
| US11918573B2 | Ophthalmic formulations of cetirizine and methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.